Man Group’s Altimmune ALT Stock Holding History

Man Group’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	173,872 +44,026	+34%	+$131K	﹤0.01%	2047
2026 Q1	$400K	Buy	129,846 +110,910	+586%	+$471K	﹤0.01%	2138
2025 Q4	$68.4K	Buy	+18,936	New	+$82.6K	﹤0.01%	2216
2023 Q3	–	Sell	-32,723	Closed	-$93.9K	–	1792
2023 Q2	$116K	Buy	+32,723	New	+$147K	﹤0.01%	1871
2023 Q1	–	Sell	-12,226	Closed	-$145K	–	1856
2022 Q4	$201K	Buy	+12,226	New	+$137K	﹤0.01%	1769
2020 Q4	–	Sell	-16,400	Closed	-$216K	–	1812
2020 Q3	$216K	Buy	+16,400	New	+$328K	﹤0.01%	1692

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's ALT Position: Q2 2026 in Review

Man Group increased its Altimmune (ALT) stake by 34% in Q2 2026, buying an estimated $131K and bringing the position to 173,872 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #2047.

Man Group first reported a position in ALT in Q3 2020 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Man Group held 173,872 shares of Altimmune worth $529K as of Q2 2026.
Man Group bought 44,026 Altimmune shares in Q2 2026, an estimated $131K.
Altimmune made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2047 holding.
Man Group first reported a position in Altimmune in Q3 2020 and has held it in 6 quarters since.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.